pentobarbital will decrease the extent or result of trazodone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital will decrease the level or outcome of diltiazem by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital will lower the extent or outcome of midazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will decrease the level or impact of finasteride by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unknown.
pentobarbital will lessen the extent or result of isradipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unidentified.
fentanyl intranasal and pentobarbital both raise sedation. Stay clear of or Use Alternate Drug. Restrict use to sufferers for whom different treatment method choices are inadequate
pentobarbital will lower the extent or effect of oxybutynin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unknown.
The efficacy of hormonal contraceptives could be lowered. Use an alternate way of contraception or a backup technique when enzyme inducers are employed with mixed hormonal contraceptives (CHCs), and keep on backup contraception for 28 times right after discontinuing enzyme inducer to guarantee contraceptive reliability.
pentobarbital will reduce the level or effect of budesonide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will reduce the level or outcome of atogepant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Closely. Proposed atogepant dosage with concomitant use of powerful or reasonable CYP3A4 inducers is thirty mg or sixty mg qDay.
pentobarbital will decrease the extent or result of atazanavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Mysterious.
With therapeutic doses of TCAs, barbiturates boost metabolism and reduce blood concentrations of TCAs.
Coadministration of zuranolone with other CNS depressants may possibly improve impairment of psychomotor effectiveness or CNS depressant effects. click here If unavoidable, take into account dose reduction. .
Withdrawal symptoms occur in infants born to moms who get barbiturates all through the previous trimester of pregnancy